Connection

Co-Authors

This is a "connection" page, showing publications co-authored by David Meyerholz and Stanley Perlman.
Connection Strength

4.825
  1. Does common cold coronavirus infection protect against severe SARS-CoV-2 disease? J Clin Invest. 2021 01 04; 131(1).
    View in: PubMed
    Score: 0.922
  2. Middle East respiratory syndrome coronavirus Spike protein variants exhibit geographic differences in virulence. Proc Natl Acad Sci U S A. 2021 06 15; 118(24).
    View in: PubMed
    Score: 0.238
  3. Coronavirus-specific antibody production in middle-aged mice requires phospholipase A2G2D. J Clin Invest. 2021 06 01; 131(11).
    View in: PubMed
    Score: 0.237
  4. Severe Acute Respiratory Syndrome Coronavirus 2-Induced Immune Activation and Death of Monocyte-Derived Human Macrophages and Dendritic Cells. J Infect Dis. 2021 03 03; 223(5):785-795.
    View in: PubMed
    Score: 0.233
  5. COVID-19 treatments and pathogenesis including anosmia in K18-hACE2 mice. Nature. 2021 01; 589(7843):603-607.
    View in: PubMed
    Score: 0.228
  6. Microglia depletion exacerbates demyelination and impairs remyelination in a neurotropic coronavirus infection. Proc Natl Acad Sci U S A. 2020 09 29; 117(39):24464-24474.
    View in: PubMed
    Score: 0.226
  7. IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes. J Clin Invest. 2019 07 29; 129(9):3625-3639.
    View in: PubMed
    Score: 0.209
  8. Nasal priming by a murine coronavirus provides protective immunity against lethal heterologous virus pneumonia. JCI Insight. 2018 06 07; 3(11).
    View in: PubMed
    Score: 0.193
  9. Microglia are required for protection against lethal coronavirus encephalitis in mice. J Clin Invest. 2018 03 01; 128(3):931-943.
    View in: PubMed
    Score: 0.188
  10. Murine Olfactory Bulb Interneurons Survive Infection with a Neurotropic Coronavirus. J Virol. 2017 Nov 15; 91(22).
    View in: PubMed
    Score: 0.185
  11. Virus-induced inflammasome activation is suppressed by prostaglandin D2/DP1 signaling. Proc Natl Acad Sci U S A. 2017 07 03; 114(27):E5444-E5453.
    View in: PubMed
    Score: 0.180
  12. Sex-Based Differences in Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Infection. J Immunol. 2017 05 15; 198(10):4046-4053.
    View in: PubMed
    Score: 0.178
  13. The Conserved Coronavirus Macrodomain Promotes Virulence and Suppresses the Innate Immune Response during Severe Acute Respiratory Syndrome Coronavirus Infection. mBio. 2016 12 13; 7(6).
    View in: PubMed
    Score: 0.174
  14. Airway Memory CD4(+) T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses. Immunity. 2016 06 21; 44(6):1379-91.
    View in: PubMed
    Score: 0.168
  15. Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice. Cell Host Microbe. 2016 Feb 10; 19(2):181-93.
    View in: PubMed
    Score: 0.164
  16. Critical role of phospholipase A2 group IID in age-related susceptibility to severe acute respiratory syndrome-CoV infection. J Exp Med. 2015 Oct 19; 212(11):1851-68.
    View in: PubMed
    Score: 0.160
  17. The nsp3 macrodomain promotes virulence in mice with coronavirus-induced encephalitis. J Virol. 2015 Feb; 89(3):1523-36.
    View in: PubMed
    Score: 0.151
  18. Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection. J Virol. 2014 Oct; 88(19):11034-44.
    View in: PubMed
    Score: 0.147
  19. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol. 2008 Aug; 82(15):7264-75.
    View in: PubMed
    Score: 0.096
  20. Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus. J Virol. 2007 Jan; 81(2):813-21.
    View in: PubMed
    Score: 0.086
  21. Postinfection treatment with a protease inhibitor increases survival of mice with a fatal SARS-CoV-2 infection. Proc Natl Acad Sci U S A. 2021 07 20; 118(29).
    View in: PubMed
    Score: 0.060
  22. 3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV-infected mice. Sci Transl Med. 2020 08 19; 12(557).
    View in: PubMed
    Score: 0.056
  23. Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment. Cell. 2020 08 06; 182(3):734-743.e5.
    View in: PubMed
    Score: 0.055
  24. Single-Dose, Intranasal Immunization with Recombinant Parainfluenza Virus 5 Expressing Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Spike Protein Protects Mice from Fatal MERS-CoV Infection. mBio. 2020 04 07; 11(2).
    View in: PubMed
    Score: 0.055
  25. MERS coronaviruses from camels in Africa exhibit region-dependent genetic diversity. Proc Natl Acad Sci U S A. 2018 03 20; 115(12):3144-3149.
    View in: PubMed
    Score: 0.047
  26. Mouse-adapted MERS coronavirus causes lethal lung disease in human DPP4 knockin mice. Proc Natl Acad Sci U S A. 2017 04 11; 114(15):E3119-E3128.
    View in: PubMed
    Score: 0.044
  27. Middle East Respiratory Syndrome Coronavirus Causes Multiple Organ Damage and Lethal Disease in Mice Transgenic for Human Dipeptidyl Peptidase 4. J Infect Dis. 2016 Mar 01; 213(5):712-22.
    View in: PubMed
    Score: 0.040
  28. Protective Effect of Intranasal Regimens Containing Peptidic Middle East Respiratory Syndrome Coronavirus Fusion Inhibitor Against MERS-CoV Infection. J Infect Dis. 2015 Dec 15; 212(12):1894-903.
    View in: PubMed
    Score: 0.039
  29. Passive immunotherapy with dromedary immune serum in an experimental animal model for Middle East respiratory syndrome coronavirus infection. J Virol. 2015 Jun; 89(11):6117-20.
    View in: PubMed
    Score: 0.039
  30. Rhesus theta-defensin prevents death in a mouse model of severe acute respiratory syndrome coronavirus pulmonary disease. J Virol. 2009 Nov; 83(21):11385-90.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.